Loading...
Loading...
Toggle sidebar
Search Ctrl + K
Filing information
TAKEDA PHARMACEUTICAL CO LTD
Filing: 20-F
Filed On: 2024-06-26
Email Link to Filing
Print Filing
Download PDF
Download all tables
Your filing highlights
Compare documents
EDGAR Index Page
Documents
20-F
20-F
EX-11.1
Statement re computation of per share earnings
EX-12.1
Statements re computation of ratios
EX-12.2
exhibit122_062624.htm
EX-13.1
Annual report to security holders, Form 10-Q and 10-QSB, or quarterly report to security holders
EX-13.2
exhibit132_062624.htm
EX-15.1
Letter re unaudited interim financial information
EX-97.1
exhibit971_062624.htm
GRAPHIC
exhibit111_062624x001.jpg
GRAPHIC
exhibit111_062624x002.jpg
GRAPHIC
exhibit111_062624x003.jpg
GRAPHIC
exhibit111_062624x004.jpg
GRAPHIC
exhibit111_062624x005.jpg
GRAPHIC
exhibit111_062624x006.jpg
GRAPHIC
exhibit111_062624x007.jpg
GRAPHIC
logo1_ex971.jpg
GRAPHIC
logo2_ex971.jpg
GRAPHIC
tak-20240331_g1.jpg
GRAPHIC
tak-20240331_g2.jpg
GRAPHIC
tak-20240331_g3.jpg
GRAPHIC
tak-20240331_g4.jpg
GRAPHIC
tak-20240331_g5.jpg
GRAPHIC
tak-20240331_g6.jpg
GRAPHIC
tak-20240331_g7.jpg
0001395064-24-000086.txt
Data files
EX-101.SCH
tak-20240331.xsd
EX-101.CAL
tak-20240331_cal.xml
EX-101.DEF
tak-20240331_def.xml
EX-101.LAB
tak-20240331_lab.xml
EX-101.PRE
tak-20240331_pre.xml
XML
tak-20240331_htm.xml
Free Trial
Save highlight
Link to highlight
Your browser does not support iframes.